Meta-analysis associates deep sedation with increased delirium and mortality in ICU patients
This meta-analysis evaluated 3,466 patients in the intensive care unit to assess the impact of deep sedation on clinical outcomes. The researchers synthesized data regarding the incidence of delirium, mortality, and ICU length of stay (LOS).
The analysis found that deep sedation was significantly associated with a higher incidence of delirium (OR: 1.34; 95% CI: 1.15 to 1.57; P = 0.0001). Furthermore, deep sedation was significantly linked to increased mortality (OR: 1.71; 95% CI: 1.32 to 2.21; P < 0.0001) and a prolonged ICU LOS (MD: 1.17 days; 95% CI: 0.54 to 1.81; P = 0.0003). Regarding dexmedetomidine specifically, the evidence was insufficient to draw a definitive conclusion on its effect on delirium incidence (OR: 0.93; 95% CI: 0.57 to 1.51; P = 0.77).
Several limitations must be considered. The overall quality of evidence was rated as Moderate by GRADE assessment, primarily due to residual confounding in cohort studies. Additionally, the secondary analysis of dexmedetomidine was limited by a small number of studies and low statistical power. Because these findings are based on associations, they do not establish causation.
Clinically, these results suggest that implementing sedation protocols prioritizing lighter sedation depth may be associated with improved ICU patient prognative outcomes.